Literature DB >> 22527228

Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab.

I Bot, C U Blank, D Brandsma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22527228     DOI： 10.1007/s00415-012-6488-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.

Authors:  C S Straathof; H G de Bruin; D W Dippel; C J Vecht
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

3.  Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.

Authors:  Noël E C Schartz; Cécile Farges; Isabelle Madelaine; Heriberto Bruzzoni; Fabien Calvo; Axel Hoos; Céleste Lebbé
Journal:  Melanoma Res       Date:  2010-06       Impact factor: 3.599

4.  Imaging features of leptomeningeal metastases.

Authors:  D A Collie; J P Brush; G A Lammie; R Grant; I Kunkler; R Leonard; A Gregor; R J Sellar
Journal:  Clin Radiol       Date:  1999-11       Impact factor: 2.350

5.  Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.

Authors:  Amit A Lugade; James P Moran; Scott A Gerber; Robert C Rose; John G Frelinger; Edith M Lord
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

Review 6.  [Guideline 'Leptomeningeal metastases of solid tumours'].

Authors:  W Boogerd; W F J du Bois; J L J M Teepen; C J G M Rosenbrand
Journal:  Ned Tijdschr Geneeskd       Date:  2007-01-13

7.  CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS.

Authors:  F Stephen Hodi; Darryl A Oble; Jan Drappatz; Elsa F Velazquez; Nikhil Ramaiya; Naren Ramakrishna; Arthur L Day; Andrea Kruse; Suzanne Mac Rae; Axel Hoos; Martin Mihm
Journal:  Nat Clin Pract Oncol       Date:  2008-07-29

8.  Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.

Authors:  R J Freilich; G Krol; L M DeAngelis
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

9.  Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.

Authors:  M Zahidunnabi Dewan; Ashley E Galloway; Noriko Kawashima; J Keith Dewyngaert; James S Babb; Silvia C Formenti; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

10.  Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.

Authors:  Laura Harstad; Kenneth R Hess; Morris D Groves
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300
  10 in total
  22 in total

1.  Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.

Authors:  Inna Smalley; Vincent Law; Clayton Wyatt; Brittany Evernden; Bin Fang; John M Koomen; Eric A Welsh; Robert J B Macaulay; Peter A Forsyth; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

Review 2.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

Review 3.  Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Authors:  Keiran S M Smalley; Inna V Fedorenko; Rajappa S Kenchappa; Solmaz Sahebjam; Peter A Forsyth
Journal:  Int J Cancer       Date:  2016-04-30       Impact factor: 7.396

4.  Ipilimumab and whole brain radiation therapy for melanoma brain metastases.

Authors:  Naamit K Gerber; Robert J Young; Christopher A Barker; Jedd D Wolchok; Timothy A Chan; Yoshiya Yamada; Leigh Friguglietti; Kathryn Beal
Journal:  J Neurooncol       Date:  2014-10-02       Impact factor: 4.130

5.  Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient.

Authors:  Richard C Wu; William Newman; Liron Patanowitz; Barton F Branstetter; Nduka Amankulor; Ahmad A Tarhini
Journal:  Immunotherapy       Date:  2020-06-22       Impact factor: 4.196

Review 6.  Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.

Authors:  Gabriella Szatmáry
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

Review 7.  Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.

Authors:  Freddy E Escorcia; Michael A Postow; Christopher A Barker
Journal:  Cancer J       Date:  2017 Jan/Feb       Impact factor: 3.360

Review 8.  Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma.

Authors:  Christopher A Barker; Michael A Postow; Shaheer A Khan; Kathryn Beal; Preeti K Parhar; Yoshiya Yamada; Nancy Y Lee; Jedd D Wolchok
Journal:  Cancer Immunol Res       Date:  2013-07-25       Impact factor: 11.151

9.  Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.

Authors:  Isabella C Glitza; Cara Haymaker; Chantale Bernatchez; Luis Vence; Michelle Rohlfs; Jessie Richard; Carol Lacey; Rahmatu Mansaray; Orenthial J Fulbright; Renjith Ramachandran; Christopher Toth; Seth Wardell; Sapna P Patel; Scott E Woodman; Wen-Jen Hwu; Laszlo G Radvanyi; Michael A Davies; Nicholas E Papadopoulos; Patrick Hwu
Journal:  Cancer Immunol Res       Date:  2015-07-27       Impact factor: 11.151

Review 10.  Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes.

Authors:  Christopher A Barker; Michael A Postow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.